{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T01:45:27Z","timestamp":1648863927225},"reference-count":78,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1157\/13077121","type":"journal-article","created":{"date-parts":[[2005,7,19]],"date-time":"2005-07-19T14:46:39Z","timestamp":1121784399000},"page":"341-351","source":"Crossref","is-referenced-by-count":0,"title":["Tratamiento de la p\u00e9rdida de masa \u00f3sea en la mujer postmenop\u00e1usica"],"prefix":"10.1016","volume":"205","author":[{"given":"L.","family":"Carre\u00f1o P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13077121_bib1","doi-asserted-by":"crossref","unstructured":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy. JAMA. 2001;285:785-95.","DOI":"10.1001\/jama.285.6.785"},{"key":"10.1157\/13077121_bib2","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1359\/jbmr.2001.16.12.2163","article-title":"Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture","volume":"16","author":"Chesnut","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1157\/13077121_bib3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1359\/jbmr.1999.14.5.821","article-title":"Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures","volume":"14","author":"Black","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1157\/13077121_bib4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/jama.285.3.320","article-title":"Risk of new vertebral fracture in the year following a fracture","volume":"285","author":"Lindsay","year":"2001","journal-title":"JAMA"},{"issue":"Suppl 10","key":"10.1157\/13077121_bib5","first-page":"S1","article-title":"2002 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada","volume":"167","author":"Brown","year":"2002","journal-title":"CMAJ"},{"key":"10.1157\/13077121_bib6","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/er.2001-9002","article-title":"IX Summary of meta-analysis of therapies for postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocrin Rev"},{"key":"10.1157\/13077121_bib7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1185\/030079904125003269","article-title":"Putting evidence-medicine based into clinical practice: comparing antiresorptive agents for the treatment of osteoporosis","volume":"20","author":"Wehren","year":"2004","journal-title":"Curr Med Res"},{"key":"10.1157\/13077121_bib8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1210\/jcem-73-3-533","article-title":"Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age","volume":"73","author":"Elders","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1157\/13077121_bib9","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM199009273231305","article-title":"A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women","volume":"323","author":"Dawson-Hughes","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1157\/13077121_bib10","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1359\/jbmr.1997.12.9.1321","article-title":"Calcium for prevention of osteoporotic fractures in postmenopausal women","volume":"12","author":"Cumming","year":"1997","journal-title":"J Bone Min Res"},{"key":"10.1157\/13077121_bib11","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1001\/jama.281.16.1505","article-title":"Occult vitamin D deficiency in postmenopausal US women with acute hip fracture","volume":"28","author":"Le Boff","year":"1999","journal-title":"JAMA"},{"key":"10.1157\/13077121_bib12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/0003-4819-113-9-649","article-title":"Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol: A randomized controlled study","volume":"113","author":"Gallagher","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1157\/13077121_bib13","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1056\/NEJM199709043371003","article-title":"Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older","volume":"337","author":"Dawson-Hughes","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1157\/13077121_bib14","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.7326\/0003-4819-117-12-1038","volume":"117","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1157\/13077121_bib15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1210\/er.2001-5002","article-title":"V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women","volume":"23","author":"Wells","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1157\/13077121_bib16","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1001\/jama.285.22.2891","article-title":"Hormone replacement therapy and prevention of non vertebral fractures: a meta-analisis of randomized trials","volume":"285","author":"Torgerson","year":"2001","journal-title":"J Am Med Assoc"},{"key":"10.1157\/13077121_bib17","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effect of estrogen plus progestin on risk of fracture and bone mineral density","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"key":"10.1157\/13077121_bib18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00198-003-1535-8","article-title":"Pulsed estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study","volume":"15","author":"Nielsen","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1157\/13077121_bib19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/00003495-199957050-00001","article-title":"Selective estrogen receptor modulators: a look ahead","volume":"57","author":"Mitlak","year":"1999","journal-title":"Drugs"},{"key":"10.1157\/13077121_bib20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0165-6147(98)01252-8","article-title":"Steroidal and nonsteroidal oestrogen antagonist in breast cancer: basic and clinical apraisal","volume":"19","author":"Favoni","year":"1998","journal-title":"Trends Farmacol Sci"},{"issue":"Extr. 3","key":"10.1157\/13077121_bib21","first-page":"51","article-title":"Lugar de los moduladores selectivos de los receptores estrog\u00e9nicos en el tratamiento de la mujer postmenop\u00e1usica","author":"Calaf Alsina","year":"2002","journal-title":"Rev Clin Esp"},{"key":"10.1157\/13077121_bib22","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/er.2001-4002","article-title":"IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1157\/13077121_bib23","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifeno: results from a 3-year randomized clinical trial. Multiple outcomes of raloxifeno evaluation (MORE) investigators","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1157\/13077121_bib24","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S8756-3282(03)00241-2","article-title":"Severity of prevalent fractures and the risk of subsequent vertebral and no vertebral fractures: results from the MORE trial","volume":"33","author":"Delmas","year":"2003","journal-title":"BONE"},{"key":"10.1157\/13077121_bib25","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.279.18.1445","article-title":"Effects of raloxifeno on serum lipids and coagulation factors in healthy postmenopausal women","volume":"279","author":"Walsh","year":"1998","journal-title":"JAMA"},{"key":"10.1157\/13077121_bib26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jama.287.7.847","article-title":"Raloxifeno and cardiovascular events in osteoporosis postmenopausal women. Four-year results from de MORE\/Multiple outcomes of raloxifeno evaluation) randomized trial","volume":"287","author":"Barret-Connor","year":"2002","journal-title":"JAMA"},{"key":"10.1157\/13077121_bib27","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1471-0528.1999.tb08367.x","article-title":"Prevention of postmenopausal bone loss at lumbar spine and upper f\u00e9mur with tibolona: a two-year randomised controlled trial","volume":"106","author":"Beardsworth","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1157\/13077121_bib28","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1210\/jc.86.10.4717","article-title":"Prevention of bone loo with tibolona in postmenopausal women: results of two randomized, double-blind, placebo- controlled, dose-findings studies","volume":"86","author":"Gallagher","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1157\/13077121_bib29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0378-5122(02)00158-5","article-title":"Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial","volume":"42","author":"Chiechi","year":"2002","journal-title":"Maturitas"},{"key":"10.1157\/13077121_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/152460902753473462","article-title":"Phytoestrogen and multiple vitamin\/mineral effects on bone mineral density in early postmenopausal women: a pilot study","volume":"11","author":"Cook","year":"2002","journal-title":"Women's Health Gend Based Med"},{"issue":"10","key":"10.1157\/13077121_bib31","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1210\/jc.2003-030290","article-title":"Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind randomized-controlled trial","volume":"88","author":"Chen","year":"2003","journal-title":"J Clin Endoc Metab"},{"key":"10.1157\/13077121_bib32","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1210\/er.2001-6002","article-title":"VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1157\/13077121_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02556587","article-title":"Effects of salmon calcitonin in postmenopausal osteoporosis: A controlled double blind clinical study","volume":"38","author":"Mazzuoli","year":"1986","journal-title":"Calcif Tissue Int"},{"key":"10.1157\/13077121_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF00301638","article-title":"An effective regimen of intranasal salmon calcitonin in early postmenopausal bone loss","volume":"50","author":"Gennari C Agnusdei","year":"1992","journal-title":"Calcif Tissue Int"},{"key":"10.1157\/13077121_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01622285","article-title":"Calcitonin versus etidronate for the treatment of postmenopausal osteoporosis: a meta-analisis of published clinical trials","volume":"7","author":"Cardona","year":"1997","journal-title":"Osteoporos Int"},{"key":"10.1157\/13077121_bib36","first-page":"267","article-title":"A randomized trial of nasal spray salmon calcitonin in postmenopausal women with stablished osteoporosis: the prevent recurrence of osteoporotic fractures study","volume":"109","author":"Chesnut","year":"2000","journal-title":"PROOF Study Group Am J Med"},{"key":"10.1157\/13077121_bib37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF03324278","article-title":"Analgesic effect of intranasal and intramuscular salmon calcitonin in postmenopausal osteoporosis: a double blind, double placebo study","volume":"6","author":"Pontiroli","year":"1994","journal-title":"Agin Clin Exp Res"},{"key":"10.1157\/13077121_bib38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/17453674.1997.11744761","article-title":"Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures: a double blind placebo controlled study","volume":"68","author":"Lyritis","year":"1997","journal-title":"Acta Orthop Scand"},{"key":"10.1157\/13077121_bib39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","article-title":"Bisphosphonates: from the laboratory to the clinic and back again","volume":"25","author":"Russell","year":"1999","journal-title":"Bone"},{"key":"10.1157\/13077121_bib40","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1185\/030079904125004475","article-title":"Bone safety of long-term bisphosphonate treatment","volume":"20","author":"Rodan","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1157\/13077121_bib41","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM199005033221803","article-title":"Effect of intermittent cyclical etidronate theraphy on bone mass and fracture rate in women with postmenopausal osteoporosis","volume":"322","author":"Storm","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1157\/13077121_bib42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199007123230201","article-title":"Inttermitent cyclical etidronate treatment of postmenopausal osteoporosis","volume":"323","author":"Watts","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1157\/13077121_bib43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S8756-3282(00)00303-3","article-title":"Cyclical etidronate versus sodium fluoride in established postmenopausal osteoporosis: a randomized 3-year trial","volume":"27","author":"Gua\u00f1abens","year":"2000","journal-title":"Bone"},{"key":"10.1157\/13077121_bib44","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1210\/jc.82.9.2784","article-title":"Prevention of early postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo-controlled study and 1-year follow-up)","volume":"82","author":"Meunier","year":"1997","journal-title":"J Clin Endocrine Metab"},{"key":"10.1157\/13077121_bib45","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF01621876","article-title":"Bone histomorphometry","volume":"3","author":"Melsen","year":"1989","journal-title":"Osteoporos Int"},{"key":"10.1157\/13077121_bib46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00301675","article-title":"Antiresorptive drug and trabecular bone turnover: validation and testing of a computer model","volume":"54","author":"Lacy","year":"1994","journal-title":"Calcif Tissue Int"},{"key":"10.1157\/13077121_bib47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00774-003-0464-0","article-title":"Long-term effect of intermittent cyclical etidronate on microarchitecture and quality of trabecular bone in an elderly woman with severe osteoporosis","volume":"22","author":"Nakatsuka","year":"2004","journal-title":"J Bone Mineral Metab"},{"key":"10.1157\/13077121_bib48","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0002-9343(99)80134-X","article-title":"Alendronate treatment of the postmenopausal osteoporotic women: effect of multiple dosages on bone mass and bone remodelling","volume":"99","author":"Chesnut","year":"1995","journal-title":"Am J Med"},{"key":"10.1157\/13077121_bib49","doi-asserted-by":"crossref","unstructured":"Schnitzer T, Bone HG, Crepaldi G, Adami S, McClung M, Kied D, et al. Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Aging (Milano). 200;12:1-12.","DOI":"10.1007\/BF03339822"},{"key":"10.1157\/13077121_bib50","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/er.2001-2002","article-title":"II. Meta-analysis of alendronate for the treatment of postmenopausal women","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1157\/13077121_bib51","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1157\/13077121_bib52","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1157\/13077121_bib53","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"10.1157\/13077121_bib54","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1157\/13077121_bib55","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effecs of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"10.1157\/13077121_bib56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis","volume":"11","author":"Reginster","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1157\/13077121_bib57","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1210\/er.2001-3002","article-title":"Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1157\/13077121_bib58","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group","volume":"344","author":"McClung","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1157\/13077121_bib59","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1185\/030079903125003125","article-title":"Efficacy of risedronate on clinical vertebral fractures within six months","volume":"20","author":"Roux","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1157\/13077121_bib60","doi-asserted-by":"crossref","DOI":"10.1007\/s00223-004-0286-7","article-title":"Seven years of treatment with risedronate in women with postmenopausal osteoporosis","author":"Mellstr\u00f6m","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"10.1157\/13077121_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.0954-6820.2003.01258.x","article-title":"Preventing osteoporotic fractures with antirrerorptive therapy: implications of michroarqchitectural changes","volume":"25","author":"Boonen","year":"2004","journal-title":"J Int Med"},{"key":"10.1157\/13077121_bib62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00223-002-2011-8","article-title":"The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis","volume":"71","author":"Brown","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"10.1157\/13077121_bib63","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1053\/gast.2000.16517","article-title":"Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women","volume":"119","author":"Lanza","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1157\/13077121_bib64","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)02342-8","article-title":"Randomised controlled study of effect of parathyroid hormone on vertebralbone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis","volume":"350","author":"Lindsay","year":"1997","journal-title":"Lancet"},{"key":"10.1157\/13077121_bib65","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/01.bor.0000129721.98691.cb","article-title":"Parathyroid hormone: evolving therapeutic concepts","volume":"16","author":"Lane","year":"2004","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl 1","key":"10.1157\/13077121_bib66","first-page":"S175","article-title":"A randomized, controlled, multicenter study of 1-84 hPTH for treatment of postmenopausal osteoporosis","volume":"23","author":"Lindsay","year":"1998","journal-title":"Bone"},{"key":"10.1157\/13077121_bib67","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1157\/13077121_bib68","doi-asserted-by":"crossref","first-page":"678","DOI":"10.7326\/0003-4819-111-8-678","article-title":"Fluoride therapy for the vertebral crush fracture syndrome. A status report","volume":"111","author":"Heaney","year":"1989","journal-title":"Ann Int Med"},{"key":"10.1157\/13077121_bib69","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s001980050041","article-title":"Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVO Study","volume":"8","author":"Menieur","year":"1998","journal-title":"Osteoporos Int"},{"key":"10.1157\/13077121_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-129-1-199807010-00001","article-title":"The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis: a randomized, controlled trial","volume":"129","author":"Reginster","year":"1998","journal-title":"Ann Int Med"},{"key":"10.1157\/13077121_bib71","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1056\/NEJM199003223221203","article-title":"Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis","volume":"322","author":"Rigg","year":"1990","journal-title":"N Eng J Med"},{"key":"10.1157\/13077121_bib72","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0002-9343(98)00029-1","article-title":"A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis","volume":"104","author":"Wimalawansa","year":"1998","journal-title":"Am J Med"},{"key":"10.1157\/13077121_bib73","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1210\/jc.87.3.985","article-title":"Additive effects of raloxifeno and alendronate on bone density and biochemical markers of bone remodelling in postmenopausal women with osteoporosis","volume":"87","author":"Johnell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1157\/13077121_bib74","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1210\/jc.87.3.983","article-title":"Editorial: For osteoporosis, are two antiresorptive drugs better than one?","volume":"87","author":"Ettinger","year":"2002","journal-title":"J Clin Endocrinol Met"},{"key":"10.1157\/13077121_bib75","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis","volume":"49","author":"Black","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1157\/13077121_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s001980050109","article-title":"The effect of exercise training programs on bone mase: a meta-analysis of published controlled trials in pre and postmenopausal women","volume":"9","author":"Wolff","year":"1999","journal-title":"Osteopor Int"},{"key":"10.1157\/13077121_bib77","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s001980170069","article-title":"The effect of lifestyle\u2019dietary daire intake, and diabetes on bone density and vertebral deformity prevalence: the EVOS Study","volume":"12","author":"Lunt","year":"2001","journal-title":"Osteoporos Int"},{"key":"10.1157\/13077121_bib78","first-page":"298","article-title":"Treatment of osteoporosis: why, whom, when, and how to treat","volume":"180","author":"Seeman","year":"2004","journal-title":"MJA"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256505725728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256505725728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T08:19:19Z","timestamp":1586333959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014256505725728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":78,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0014256505725728"],"URL":"https:\/\/doi.org\/10.1157\/13077121","relation":{},"ISSN":["0014-2565"],"issn-type":[{"value":"0014-2565","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}